Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies.

Journal Article

Study participants were asked about their interest in switching to novel drug delivery systems that reduce the dosing frequency of antiretroviral regimens. Across a diverse, treatment-experienced cohort, we describe greatest interest in switching to an oral regimen taken once weekly, followed by injections taken every other month and twice-annual implants.

Full Text

Duke Authors

Cited Authors

  • Derrick, CB; Ostermann, J; Weissman, SB; Hobbie, A; Alshareef, N; Weinhold, A; Yelverton, V; Thielman, NM

Published Date

  • October 22, 2018

Published In

Volume / Issue

  • 5 / 10

Start / End Page

  • ofy247 -

PubMed ID

  • 30364593

Pubmed Central ID

  • 30364593

Electronic International Standard Serial Number (EISSN)

  • 2328-8957

International Standard Serial Number (ISSN)

  • 2328-8957

Digital Object Identifier (DOI)

  • 10.1093/ofid/ofy247

Language

  • eng